NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
2
Data completeness
2/8 — Basic
AMINOSOL 5% (protein hydrolysate) by AbbVie. Approved for sarcopenia.
Drug data last refreshed 2w ago
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Clinical Trials (2)
The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Started Sep 2025
75 enrolled
Sarcopenia in ElderlyMalnourishedProtein Supplementation+3 more
A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates
Started Mar 2011
86 enrolled
Cow Milk Allergy
Worked on AMINOSOL 5% at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.